1-methyl-3-isobutylxanthine has been researched along with 6-bromoindirubin-3'-oxime in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atashi, A; Chavoshi, MS; Dastjerdi, FV; Najafabadi, IK; Shahraz, A; Soleimani, M; Tafreshi, AP; Vardanjani, MM; Zeynali, B | 1 |
1 other study(ies) available for 1-methyl-3-isobutylxanthine and 6-bromoindirubin-3'-oxime
Article | Year |
---|---|
Inhibition of GSK-3β enhances neural differentiation in unrestricted somatic stem cells.
Topics: 1-Methyl-3-isobutylxanthine; Active Transport, Cell Nucleus; beta Catenin; Blotting, Western; Cell Nucleus; Cells, Cultured; Fetal Blood; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Immunohistochemistry; Indoles; Neurogenesis; Oximes; Stem Cells; Time Factors; Tretinoin; Tubulin; Wnt Signaling Pathway | 2012 |